Member Info for CJ39

Well you’ve done alright there, takes a bit of nerve to sell out like that before the dividend but sounds like you did make a bit extra doing what you did. I do agree if you want to hold Aviva to collect dividends, ideally you do want to trade them throughout the year selling/buying on highs and lows but it’s not easy.

I do wonder if we will now see a surge in the Aviva share price to around the 450p mark now, It just feels to me that market makers have prolonged this decline in share price wanting people to sell at these low prices before raising it quickly back to old levels so people have to pay a lot more for the shares. We’ll see.

Just wondering what the fella did who sold out before the dividend did. He could have done alright out of it when selling at 383p and buying in around 367p but if he didn’t buy back in then he’s made a pickle for himself.

When that RNS came out 11 months ago I bought in thinking this was a share with amazing potential, they still had the best part of £7.5m in the bank, they announced this deal EVG would receive $6m by the end of 2023 which would secure a cash runway to somewhere into 2025. They had the Juvenesense deal which was going to be an income stream. There was lot more things happening with other trials.

11 months on and where is EVG at? The $6m to be received by the end of 2023 became ‘Up to $6m anticipated by end of 2024’, no explanation given for that. Juvenesense pulled the plug, no real explanation behind it. Cash is running out fast, it was £5m almost 6 months ago, it must be somewhere around the £3m mark now (and bear in mind that EVG issued the last two share placings when there was £1.5m left in the bank). It took the best part of 6 months to make sure the new tablet was safe. Now they have announced they will start analysing a large and complex dataset as part of the Stalicla deal. How long is that going to take? As for other trials they announced in the QnA that they need to secure a partnership to do clinical trials with SFX-01 to help treat breast cancer as it’s too expensive for EVG to do that. Hugh went to California to do some networking but no news of anything.

The share price is at its lowest ever point, they need big news and significant money incoming very soon otherwise a share placing at these low prices will dilute the shares so much that it will become impossible for shareholders to ever get their money back. You can see now why no one associated with EVG were buying shares, they knew.

Sadly it’s looking like yet another AIM share that managed to lure in suckers to lose their money.

I mean of course we are, we’ve had 5 months of constant decline. Thank goodness the results were positive otherwise we would be even lower.

If this does return to 440p I’m out and never touching UK stock market again, it’s poison, all I see is people losing money. Let’s hope everyone stops investing in it.

Got to agree with Porsche too. The UK stock market is awful, we are all wasting our time and money here, and never rewarded for having our money in the markets which can go horribly wrong. It is really hard to make money, I bet most have lost a lot and that really isn’t the aim when it comes to investing.

AIM companies are literally a con, companies created and financed by endless share placings to pay good salaries to directors who specialise in failure.

The FTSE100 companies, show me one company who’s share price has performed really well over the last 5 years. The likes of Lloyds have lost over 30%, Tesco no change in 5 years, Aviva down about 20%, Unilever down about 10%, etc. I’ve seen some friends make a fortune on crypto, like 1000% ROI in very short period of time.

It really is time everyone looked elsewhere to try and make their money grow.

I’m no expert, I focus on a few shares that I have followed for years. I can’t personally understand why Aviva has seen a 20% fall in share price in the last 5 months. From what I can see all is going just fine.

It makes me think is the share price being kept low for a prolonged period of time so that people sell out at these very low levels before the share price will be taken up sharping so anyone buying in has to buy in at much higher prices.

Or am I talking nonsense?

Today the FTSE 100 index is up 35 points but Aviva is down again. Investing in shares is really psssing me off, it’s like we are all being taken for suckers on every share, whether it’s AIM or the big Companies. I’ll be selling out and putting my money in savings accounts once I’m back level. I encourage anyone new to not bother with shares, it’s a complete circus.

Look at that share price, in the 360 pences, that’s seriously low. Back on March 9th we were on 462p and has anything negative happened to Aviva to warrant a 93p drop in share price, down 20%?

I am starting to hate investing in shares, I got lied to by an AIM company I was invested in, whilst here Aviva’s results were really good and yet 20% down in 5 months. Seriously what is the point having your money in shares when it can be safe in an ISA or premium bonds and guaranteed to make returns. There is no point to holding Aviva shares now that the interest rate can give decent returns, it was a different story when the interest rate was like 0.5% for so long.

When the FTSE 100 index reached over 8000 points I read experts saying that we had seen the last of 7500 for the FTSE 100. Now the index is really low, if experts couldn’t see this coming so soon then what hope does the average investor? But even when the FTSE was so high Aviva was not seeing any positive impact on the share price.

Add to that the capital gains limits have decreased significantly now, what incentive is there to buy shares? It’s a joke.

I see the whole insurance sector has struggled since March, it’s not just Aviva but I do feel that this is a very unfair share price given the latest results.

No doubt it will turn but once I have got my money back I’m out of this circus.

Retirement, you’re not going to let him speak to you like that are you? I’d be swinging punches if someone talked to me like that.

Tivman, well the last two share placings raised £10-£11m so I’m guessing that is what they will do again. Doesn’t seem much point raising just £5m if that’s only going to last 18 months to 2 years.

I’ll be surprised if for the 2023/2024 year that the costs will be less than £3.5m and EVG maybe able to hold off a share placing with less than £1m in the bank but surely not much less than that.

Flash, you took that snippet from the RNS regarding the Stalicla deal 10/10/2022:

· $0.5m upfront, $0.5m on completion of Phase 1 study (anticipated during Q2 2023). Milestone payments including $5m on grant of IND by the FDA (anticipated in late 2023).

It then was reported in the Half year report 08/12/2022:

Up to $6m in initial milestones to be received before end 2023.

And then in the Final results 07/06/2023:

Milestone payments from STALICLA collaboration expected during the year with up to $5.5m anticipated by 31 December 2024

There was no explanation why this went from ‘will be received before end of 2023” to now ‘anticipated by 31/12/2024’

I personally can’t believe they did that, saying $6m would be received by the end of this year when it’s not, that was why I bought in, thinking the company would be fully funded definitely until sometime in 2025.

How therefore can you trust that the money will be received in time to avert a share placing? Because right now the money in the bank must be about £3.5m. The last share placing was done when there was £1.5m in the bank.

Kev, you really should listen to KingAlf, Radar and I. We are like your guardian angels, the good guys on your shoulder trying to tell you don’t lose your money. The people who are positive about EVG are like the devil, the bad guy on your shoulder telling you to do it and take the risk and lose your money.

You’ll see in time that you should have listened to us.

KingAlf has been here for years, you really should show him more respect.

I’ve got to agree with Alf, my neighbour is autistic, I can’t imagine a broccoli tablet would cure him either. The brain is too complex and not possible to remedy so many conditions.

If the trials find that SFX-01 has no positive impact then Stalicla will soon pull the plug on the deal, just like Juvenesence did and where will that leave EVG?

In the RNS this week it said ‘Further analysis will be undertaken on this large and complex dataset to gain insight into the particular genes identified’. How long is that going to take? This share is known to go two months without any news, it happened between 22/03 to 26/05, 25/01 - 13/03, last year 22/07 - 29/09. It may be a slow news stream between now and the end of the year and that always sees the share price drop further.

Those who think this is nailed on to succeed are living in cuckoo land.

I honestly don’t think you need to be invested in this right now. If things go well you’ll be able to buy in and make good money.

King Alf, you’re not going to let Kev speak to you like that are you?

The share price here has been hammered in the last five months, down 18%, from 462p on March 9th to 379p yesterday yet the results are always solid. No matter what the market conditions Aviva perform really well. We didn’t even go up when the markets reached 8000 but have been pummelled when the markets have dropped. It’s about time the tide turned here.

On Target, how much money do you think EVG have in the bank right now? It was £5.0m at 31/03/2023. So about £3.5m-£3.7m? The last share placing in Feb 2021 was done with £1.5m in the bank.

EVG have said the $6m Stalicla payment next due is expected by the end of 2024. So how do you expect EVG to not issue a share placing sometime in the first half of 2024? How will they trade without money? You say that we are trolls, we are simply stating facts.

Kev, I liked your post at 08:13. You wrote:

MMs have no stock to sell, hence the spread. They aren’t having mine. I’m interested to see what a $160m payment from Stalicla does to the sp. GLA.

They have no stock to sell? Since the Juvenesence announcement there has been huge sells. And the Stalicla payment next due is $6m, you do realise that don’t you? And that’s not expected for over a year away.

Flash, yes you have summed up my thoughts exactly. I believe EVG have something in the SFX-01 drug and if only they had significant cash reserves I’d be happy to stick around but everything here takes forever and EVG don’t have forever.

I would have liked to have known why JuvLife called time with SFX-01 after 3 years, that seems strange. In the Q&A just a week before this news announced they were excited about this partnership and money incoming.

I am sure EVG will post some positive updates in the next 6 months but it will need to be either a huge contract signed (similar to the Stalicla deal) to raise the share price or some significant amount of money incoming to avert a share placing otherwise this is doomed in terms of a good investment opportunity. Will either happen? It’s not impossible but it is unlikely IMO.

If you’re already invested here then you’d like to think the share price can’t fall much lower between now and any announcement of a share placing, and any placing is surely over 6 months away so probably is best to hold for the time being. But IMO this has gone from an exciting share to an investment disaster. I’m so disappointed, I thought I found a share here that would make me loads of money, I’m sure many others did too otherwise they wouldn’t have invested. I’ll be watching with interest, time will tell.

Forgot to tag Strong sell.

£5m cash at 31/03/2023, spending for the year 01/04/2023 - 31/03/2024 probably around £3.5m with no income expected. Think you can expect a share placing around April 2024 to raise £10m. If they do at 2p there will be approx 775m shares in issue. What value do you think EVG can reach? Currently the market cap is £6.6m. If you think they can be worth £70m, with 775m shares in issue the share price would be only 9p a share if all goes really well. This goose is cooked unless there is a big change in fortunes. I’d never invest in this now given the dwindling cash, no income to come from Juvenesence and Stalicla money not expected until late 2024.

Trickymatters, ontarget, barf - when this really goes down the toilet when the next share placing happens, I think all three of you need to apologise to Alf, Radar and myself… and put some thought into the apology please. I’m appalled by the way you have spoken to us.